Serum protease-activated receptor (PAR-1) levels as a potential biomarker for diagnosis of inflammation in type 2 diabetic patients

被引：0
|
作者：
Sanjay Goyal
Ankita Sood
Isha Gautam
Soumyadip Pradhan
Puskar Mondal
Gaaminepreet Singh
Ravinder Singh Jaura
Thakur Gurjeet Singh
Raminderpal Singh Sibia
机构：
[1] Government Medical College,
[2] Chitkara College of Pharmacy,undefined
[3] Chitkara University,undefined
来源：
Inflammopharmacology | 2022年 / 30卷
关键词：
Protease-activated receptor 1; Inflammation; Type 2 diabetes mellitus; Biomarker; Cytokines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1843 / 1851
页数：8
相关论文
共 50 条
  • [1] Serum protease-activated receptor (PAR-1) levels as a potential biomarker for diagnosis of inflammation in type 2 diabetic patients
    Goyal, Sanjay
    Sood, Ankita
    Gautam, Isha
    Pradhan, Soumyadip
    Mondal, Puskar
    Singh, Gaaminepreet
    Jaura, Ravinder Singh
    Singh, Thakur Gurjeet
    Sibia, Raminderpal Singh
    [J]. INFLAMMOPHARMACOLOGY, 2022, 30 (05) : 1843 - 1851
  • [2] Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma
    Tas, Faruk
    Bilgin, Elif
    Karabulut, Senem
    Erturk, Kayhan
    Duranyildiz, Derya
    [J]. BBA CLINICAL, 2016, 5 : 166 - 169
  • [3] Protease-Activated Receptor (par)-2 Is Required For Par-1 Signaling In Pulmonary Fibrosis
    Lin, C.
    Aberson, H. L.
    Von der Thusen, J.
    Borensztajn, K.
    Spek, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [4] Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
    Lin, Cong
    von der Thusen, Jan
    Daalhuisen, Joost
    ten Brink, Marieke
    Crestani, Bruno
    van der Poll, Tom
    Borensztajn, Keren
    Spek, C. Arnold
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (06) : 1346 - 1356
  • [5] Protease-Activated Receptor 1 (PAR-1) Antagonists as Potential Treatment for Acute Coronary Syndrome
    Abdel-Magid, Ahmed F.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (10): : 881 - 883
  • [6] Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes
    Debeir, T
    Vige, X
    Benavides, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 323 (01) : 111 - 117
  • [7] Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias
    Veiga, Camilla de S. B.
    Carneiro-Lobo, Tatiana C.
    Coelho, Claudia J. B. P.
    Carvalho, Silvia M. F.
    Maia, Raquel C.
    Vasconcelos, Flavia C.
    Abdelhay, Eliana
    Mencalha, Andre L.
    Ferreira, Aline F.
    Castro, Fabiola A.
    Monteiro, Robson Q.
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2011, 46 (03) : 230 - 234
  • [8] Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1
    Damiano, BP
    Cheung, WM
    Santulli, RJ
    Fung-Leung, WP
    Ngo, K
    Ye, RD
    Darrow, AL
    Derian, CK
    De Garavilla, L
    Andrade-Gordon, P
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 288 (02): : 671 - 678
  • [9] Cleavage of protease-activated receptor-1 (PAR-1) and platelet activation by α- and γ-thrombins
    Nyarko, KA
    Freedman, J
    Song, YQ
    Gentry, PA
    Ofosu, FA
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 817 - 817
  • [10] Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer
    Liu, Xuan
    Yu, Jiahui
    Song, Shangjin
    Yue, Xiaoqiang
    Li, Qi
    [J]. ONCOTARGET, 2017, 8 (63) : 107334 - 107345
12345